Hanna M.
- Country
- Poland
- Department
- Dermatology
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa
- Efficacy and Safety Evaluation of Bimekizumab Versus Ustekinumab in Pediatric Patients with Moderate to Severe Plaque Psoriasis
Data & Insights
Has run more than one trial at 39 of 159 partner sites.
Specializations
Dermatological Research
The investigator specializes in treating various forms of psoriasis, with particular emphasis on plaque psoriasis ranging from mild to severe manifestations.
- Mild to Moderate Psoriasis Management
- Severe Plaque Psoriasis Treatment
- Pediatric Psoriasis Care
Their work encompasses both adult and pediatric populations, focusing on innovative therapeutic approaches for dermatological conditions.
Therapeutic Innovation
The investigator explores novel immunological treatments and emerging therapies for chronic skin conditions, including both oral medications and subcutaneous administration methods.
- Novel Therapeutic Compounds
- Comparative Treatment Efficacy
- Drug Development Research
Their research encompasses various therapeutic modalities, evaluating both established and experimental treatment options.
Special Population Studies
The investigator has dedicated expertise in managing pediatric and adolescent patients with dermatological conditions, particularly focusing on ages 6 to 18 years.
- Child and Adolescent Treatment
- Age-Specific Therapeutic Approaches
- Safety Monitoring in Young Patients
Their work addresses the unique therapeutic needs and safety considerations of younger patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.